White House Health Reform Proposal Pays For Closing Part D Gap With Pharma Industry Fees
This article was originally published in The Pink Sheet Daily
Executive Summary
President's plan builds on Senate health reform bill with package of revisions that could be attached to budget reconciliation legislation.
You may also be interested in...
Final Health Reform Bill Looks Positive For Pharma Firms
It has been a long haul to get to the final iteration of proposed health care reform legislation released March 18, and it appears that the pharmaceutical industry's patience and lobbying efforts have garnered an overall positive result
Final Health Reform Bill Looks Positive For Pharma Firms
It has been a long haul to get to the final iteration of proposed health care reform legislation released March 18, and it appears that the pharmaceutical industry's patience and lobbying efforts have garnered an overall positive result
Pharma Market-Share Fees In House Health Care Reform Package Less Than Expected
Brand drug manufacturers will pay annually increasing fees until 2019, totaling $28 billion over 10 years, after which the figure drops and holds steady.